UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$948M |
| 2 |
Snowflake
SNOW
|
+$542M |
| 3 |
Sea Limited
SE
|
+$501M |
| 4 |
Procter & Gamble
PG
|
+$491M |
| 5 |
Snap
SNAP
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$434M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350M |
| 3 |
Lowe's Companies
LOW
|
+$215M |
| 4 |
Applied Materials
AMAT
|
+$186M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.21% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 12.28% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
MP Materials
MP
$9.68B
| $1.97M | ﹤0.01% |
61,020
+6,825
| +13% | +$237K |
|
1802
Revolve Group
RVLV
$1.73B
| $1.97M | ﹤0.01% |
31,813
| – | – |
|
|
AZRE
1803
DELISTED
Azure Power Global Limited
AZRE
| $1.96M | ﹤0.01% |
89,040
-13,996
| -14% | -$322K |
|
1804
Celldex Therapeutics
CLDX
$3.32B
| $1.95M | ﹤0.01% |
36,210
+2,198
| +6% | +$103K |
|
|
CGAU
1805
Centerra Gold
CGAU
$4.16B
| $1.95M | ﹤0.01% |
285,679
+39,010
| +16% | +$289K |
|
|
FLNA
1806
Filana Therapeutics
FLNA
$49.8M
| $1.94M | ﹤0.01% |
31,275
-201
| -0.6% | -$16.8K |
|
1807
Magnolia Oil & Gas
MGY
$6.13B
| $1.94M | ﹤0.01% |
109,089
-9,020
| -8% | -$136K |
|
1808
Health Catalyst
HCAT
$129M
| $1.94M | ﹤0.01% |
38,715
+2,698
| +7% | +$147K |
|
|
ADAM
1809
Adamas Trust
ADAM
$871M
| $1.94M | ﹤0.01% |
113,573
+15,959
| +16% | +$278K |
|
1810
Stewart Information Services
STC
$2.03B
| $1.93M | ﹤0.01% |
30,465
+2,013
| +7% | +$120K |
|
|
RWT
1811
Redwood Trust
RWT
$573M
| $1.93M | ﹤0.01% |
149,397
+7,328
| +5% | +$89.7K |
|
1812
Quanterix
QTRX
$116M
| $1.92M | ﹤0.01% |
38,660
+2,420
| +7% | +$125K |
|
|
LAC
1813
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $1.92M | ﹤0.01% |
86,001
-2,399
| -3% | -$42.2K |
|
1814
ESCO Technologies
ESE
$7.87B
| $1.92M | ﹤0.01% |
24,944
+1,576
| +7% | +$139K |
|
|
GBT
1815
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.91M | ﹤0.01% |
75,125
+854
| +1% | +$25.1K |
|
1816
ICF International
ICFI
$1.67B
| $1.91M | ﹤0.01% |
21,395
+2,293
| +12% | +$208K |
|
1817
TFS Financial
TFSL
$4.88B
| $1.9M | ﹤0.01% |
99,686
+3,239
| +3% | +$63.2K |
|
1818
Banner Corp
BANR
$2.4B
| $1.9M | ﹤0.01% |
34,365
| – | – |
|
1819
Tennant Co
TNC
$1.2B
| $1.89M | ﹤0.01% |
25,555
+3,097
| +14% | +$232K |
|
|
HOOK
1820
DELISTED
HOOKIPA Pharma
HOOK
| $1.89M | ﹤0.01% |
32,040
-1,081
| -3% | -$78.4K |
|
1821
Cohu
COHU
$2.41B
| $1.89M | ﹤0.01% |
59,042
-3,989
| -6% | -$136K |
|
|
MCFE
1822
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $1.88M | ﹤0.01% |
85,037
+47,769
| +128% | +$1.23M |
|
1823
Sight Sciences
SGHT
$434M
| $1.87M | ﹤0.01% |
+82,589
| New | +$2.71M |
|
1824
First Interstate BancSystem
FIBK
$3.55B
| $1.87M | ﹤0.01% |
46,343
| – | – |
|
|
VCRA
1825
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.86M | ﹤0.01% |
40,649
+2,009
| +5% | +$89.7K |
|
Similar funds
UBS AM's Q3 2021 Portfolio in Review
As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.
- UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
- UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
- UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
- UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
- UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
- UBS AM opened 56 new positions and closed 62 in Q3 2021.
- UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.
Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.